(Press-News.org) Oncotarget published "High in vitro and in vivo synergistic activity between mTORC1 and PLK1 inhibition in adenocarcinoma NSCLC" which reported that the aim of this study was therefore to define combination of treatment based on the determination of predictive markers of resistance to the mTORC1 inhibitor RAD001/Everolimus.
When looking at biomarkers of resistance by RT-PCR study, three genes were found to be highly expressed in resistant tumors, i.e., PLK1, CXCR4, and AXL.
The authors have then focused this study on the combination of RAD001 Volasertib, a PLK1 inhibitor, and observed a high antitumor activity of the combination in comparison to each monotherapy; similarly, a clear synergistic effect between the two compounds was found in an in vitro study.
Pharmacodynamics study demonstrated that this synergy was due to tumor vascularization decrease, increase of the HIF1 protein expression and decrease of the intracellular pH, and decrease of the Carbonic Anhydrase 9 protein that could not correct intracellular acidosis.
In conclusion, all these preclinical data strongly suggest that the inhibition of mTORC1 and PLK1 proteins may be a promising therapeutic approach for NSCLC patients.
All these preclinical data strongly suggest that the inhibition of mTORC1 and PLK1 proteins may be a promising therapeutic approach for NSCLC patients
Dr. Didier Decaudin from The Institut Curie said, "Specifically targeting the Pi3K signaling pathway in the treatment of non-small cell lung cancers (NSCLC) has now been proposed for more than ten years."
However, surprisingly, in the context of tumors defined by a Pi3K activation, very few clinical trials have tested single-agent Pi3K signaling pathway, all of them showing in fact a modest activity in molecularly unselected NSCLC patients, with the mTORC1 inhibitor everolimus, and the pan-Pi3K inhibitor Taselisib or Buparlisib.
Based on this rationale for the Pi3K pathway targeting in NSCLC, a huge number of clinical trials have consequently tested various Pi3K-based combination of treatments, including chemotherapies such as pemetrexed, taxanes, platinum salts, EGFR-TKi, radiotherapy, and others.
However, almost all of these combinations have been defined according to standard chemotherapies or NSCLC mutations, but not according to specific targets identified as biomarkers of resistance to Pi3K-targeting treatments.
The main strategy was therefore, using a panel of NSCLC PDXs, to define predictive markers of response to RAD001 therapy and to identify possible combinations of treatments that may be able to reverse RAD001 resistance.
Hence, using two well-documented Pi3K- and mTORC1-targeted therapies, i.e., BKM120 and RAD001, they have first evaluated in vivo responses in NSCLC Patient-Derived Xenografts, second defined marker of resistance to these two therapies that inhibition could pharmacologically be proposed, and finally evaluated a new identified and more relevant combination of treatments.
The Decaudin Research Team concluded in their Oncotarget Research Output that the determination of relevant Pi3K-based therapeutic combination was not supported, by the presence of actual molecular abnormalities, nor by physician therapeutic practices, but by the identification of predictive markers of resistance to Pi3K-based monotherapies.
The step-by-step methodology presented here highlights the useful of appropriate preclinical models of human cancers, such as PDXs; this methodology could be summarized, as follow:
Assessment and validation of an antitumor activity of a treatment X
Determination of predictive marker of resistance to the compound X
Identification of a second treatment Y able to reverse the dismal impact of a previously defined predictive marker of resistance, and
Validation of its clinical relevance in terms of its prognostic impact, assessment and validation of an antitumor activity of the combination of the treatments X Y, comprehensiveness, as far as possible, of the mechanisms of action of this new treatment combination, and, finally, clinical assessment in cancer patients.
This methodology may promote more relevant clinical trials and avoid non-efficient combinations, inacceptable toxicities, and expensive and time-consuming studies.
INFORMATION:
DOI - https://doi.org/10.18632/oncotarget.27930
Full text - https://www.oncotarget.com/article/27930/text/
Correspondence to - Didier Decaudin - Didier.decaudin@curie.fr
Keywords -
NSCLC,
Pi3K signalling pathway,
mTORC1,
RAD001 (everolimus),
PLK1
About Oncotarget
Oncotarget is a bi-weekly, peer-reviewed, open access biomedical journal covering research on all aspects of oncology.
To learn more about Oncotarget, please visit https://www.oncotarget.com or connect with:
SoundCloud - https://soundcloud.com/oncotarget
Facebook - https://www.facebook.com/Oncotarget/
Twitter - https://twitter.com/oncotarget
LinkedIn - https://www.linkedin.com/company/oncotarget
Pinterest - https://www.pinterest.com/oncotarget/
Reddit - https://www.reddit.com/user/Oncotarget/
Oncotarget is published by Impact Journals, LLC please visit https://www.ImpactJournals.com or connect with @ImpactJrnls
For decades, researchers have been working toward mitigating excess atmospheric carbon dioxide (CO2) emissions. One promising approach captures atmospheric CO2 and then, through CO2 electrolysis, converts it into value-added chemicals and intermediates--like ethanol, ethylene, and other useful chemicals. While significant research has been devoted to improving the rate and selectivity of CO2 electrolysis, reducing the energy consumption of this high-power process has been underexplored.
In ACS Energy Letters, researchers from the University of Illinois Urbana-Champaign report a new opportunity to use magnetism to reduce the energy required for CO2 electrolysis by up to 60% in a flow electrolyzer.
In a ...
PULLMAN, Wash. - Fire can put a tropical songbird's sex life on ice.
Following habitat-destroying wildfires in Australia, researchers found that many male red-backed fairywrens failed to molt into their red-and-black ornamental plumage, making them less attractive to potential mates. They also had lowered circulating testosterone, which has been associated with their showy feathers.
For the study published in the Journal of Avian Biology, the researchers also measured the birds' fat stores and the stress hormone corticosterone but found those remained at normal levels.
"Really, it ended up all coming down to testosterone," said ...
Male jackdaws don't stick around to console their mate after a traumatic experience, new research shows.
Jackdaws usually mate for life and, when breeding, females stay at the nest with eggs while males gather food.
Rival males sometimes visit the nest and attack the lone female, attempting to mate by force.
In the new study, University of Exeter researchers expected males to console their partner after these incidents by staying close and engaging in social behaviours like preening their partner's feathers.
However, males focussed on their own safety - they still brought food to the nest, but they visited less often and spent less time with the female.
"Humans often console friends or family in distress, but it's unclear whether animals do this in the wild," said Beki ...
A new analysis of 58 studies and 44305 patients published in Anaesthesia (a journal of the Association of Anaesthetists) shows that, contrary to some previous research, being male and increasing body mass index (BMI) are not associated with increased mortality in COVID-19 in patients admitted into intensive care (ICU).
However, the study, by Dr Bruce Biccard (Groote Schuur Hospital and University of Cape Town, South Africa) and colleagues finds that a wide range of factors are associated with death from COVID-19 in ICU.
Patients with COVID-19 in ICU were 40% more likely to die with a history of smoking, 54% more likely with high blood pressure, 41% more likely with diabetes, ...
This year marks the 100th anniversary of the discovery of insulin, a scientific breakthrough that transformed Type 1 diabetes, once known as juvenile diabetes or insulin-dependent diabetes, from a terminal disease into a manageable condition.
Today, Type 2 diabetes is 24 times more prevalent than Type 1. The rise in rates of obesity and incidence of Type 2 diabetes are related and require new approaches, according to University of Arizona researchers, who believe the liver may hold the key to innovative new treatments.
"All current therapeutics for ...
Los Angeles, Calif. - The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, today announced that findings from a sub-study of REPRIEVE (A5332/A5332s, an international clinical trial studying heart disease prevention in people living with HIV) have been published in the Journal of the American Medical Association Network Open (JAMA Network Open). The study found that approximately half of study participants, who were considered by traditional measures to be at low-to-moderate risk of future heart disease, had atherosclerotic plaque in their coronary arteries.
While it is well-known that people living with HIV are at ...
(OTTAWA, ON) The University of Ottawa, the University of Montreal and the Assembly of First Nations are pleased to announce the newly published First Nations Food, Nutrition and Environment Study (FNFNES) in the Canadian Journal of Public Health. Mandated by First Nations leadership across Canada through Assembly of First Nations Resolution 30 / 2007 and realized through a unique collaboration with researchers and communities, the First Nations Food, Nutrition and Environment Study is the first national study of its kind. It was led by principal investigators Dr. Laurie Chan, a professor ...
UCLA engineers have demonstrated successful integration of a novel semiconductor material into high-power computer chips to reduce heat on processors and improve their performance. The advance greatly increases energy efficiency in computers and enables heat removal beyond the best thermal-management devices currently available.
The research was led by Yongjie Hu, an associate professor of mechanical and aerospace engineering at the UCLA Samueli School of Engineering. Nature Electronics recently published the finding in this article.
Computer processors have shrunk down to nanometer scales over the years, with billions of transistors sitting on a single computer chip. While the increased number of transistors helps make computers faster and more powerful, it also generates ...
Scientists and doctors at University College London Great Ormond Street Institute of Child Health (UCL GOS ICH) and Great Ormond Street Hospital (GOSH) have given hope of a gene therapy cure to children with a rare degenerative brain disorder called Dopamine Transporter Deficiency Syndrome (DTDS).
The team have recreated and cured the disease using state-of-the-art laboratory and mouse models of the disease and will soon apply for a clinical trial of the therapy. Their breakthrough comes just a decade after the faulty gene causing the disease was first discovered by the lead scientist of this work.
The results, published in Science Translational Medicine, are so promising that the UK regulatory agency MHRA has advised ...
Boulder, Colo., USA: Article topics include the Great Unconformity of the
Rocky Mountain region; new Ediacara-type fossils; the southern Cascade arc
(California, USA); the European Alps and the Late Pleistocene glacial
maximum; Permian-Triassic ammonoid mass extinction; permafrost thaw; the
southern Rocky Mountains of Colorado (USA); "gargle dynamics"; invisible
gold; and alluvial fan deposits in Valles Marineris, Mars. These Geology articles are online at
https://geology.geoscienceworld.org/content/early/recent
.
A new kind of invisible gold in pyrite hosted in deformation-related
dislocations
Denis Fougerouse; Steven M. Reddy; Mark ...
